In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
about
Susceptibilities of anaerobic bacteria to cefoperazone and other antibioticsComparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiencyRecent bioanalytical methods for quantification of third-generation cephalosporins using HPLC and LC-MS(/MS) and their applications in pharmacokinetic studies.Penetration and clearance of cefoperazone and moxalactam in pleural fluid.In vitro activity of DQ-2556, a new cephalosporin.Cefoperazone versus clindamycin plus gentamicin for obstetric and gynecologic infections.In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.Pharmacokinetics of cefoperazone in patients with neoplastic disease.Pharmacokinetics of ceftriaxone in humans.Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis groupCeftriaxone: in vitro studies and clinical evaluationIn vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activityIn vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.Biological activity of BO-1236, a new antipseudomonal cephalosporin.In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.Purification and some properties of a cephalosporinase from Proteus vulgaris.In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.Purification and properties of a new beta-lactamase from Pseudomonas cepacia.Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.Affinity of cefoperazone for penicillin-binding proteins.In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila.Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporins.In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.Antibacterial activity of cefoperazone alone and in combination against cephalosporinase-producing Enterobacter cloacae.Properties of a new penicillinase type produced by Bacteroides fragilis.Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method.Penetration of cefoperazone into surgical wound drainage in patients undergoing head and neck surgery.Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.[N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].Elevated PT, APPT and PT/INR possibly associated with doxycycline and cefoperazone co-administration: A case report.In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
P2860
Q24628829-31653EFD-94E1-49F5-8E7A-F19819F8C1A4Q30451358-2F2B1AAC-7972-4B06-99D3-4EDA699D96CFQ30451386-6BA5AE68-1FB6-4C73-913B-DE8B7958FD2CQ35311343-22F70364-EC3D-4EDF-95F7-A6CB6BD42CC3Q35569002-ADF5257D-02DF-4E12-87AA-F60B5452462FQ35575411-EBECE388-402A-4D3C-AC68-810DBF4D64FAQ35575869-411902CB-A09D-43D3-A929-2C88FD046F0FQ35644656-0F4A55B2-E9CA-4F63-8CE9-91283FCB3B8DQ35670676-64E63A66-05E8-474D-944C-2AD0245BD82FQ35672073-B852648D-67CC-43CA-9DE4-3F57B838A553Q35672511-CFD7961E-E7D1-477C-884A-8E644CD23DC0Q35712352-8CF0426A-8DB0-4A47-B75D-E7B1FE9D2D6AQ35769371-7D340369-010C-4847-9A95-AE06E811DA1BQ39819826-3F2B49B6-F52A-4113-8406-10162C3DE59EQ39828412-61B098C9-AFC3-4635-9250-C2B4AFD14BC1Q39849584-27E2DE06-E48D-4141-9F84-F9E0E4E27CA0Q39849664-4285DD86-4BE7-4716-A062-2D7D8A2A8C4CQ39854442-D44A8F07-652F-4D3F-A54A-DA6049AF1392Q39875846-1D1D5748-5080-4EA7-8EE4-686B9B54F473Q40114571-56346A42-3037-4C19-A150-DE48E91A057BQ40215884-FA38FACD-ECEB-4F76-B4D2-78E2FFDCAAA7Q40281601-E1CD7E18-BFCB-4187-9271-BCCFEF00EDF1Q40281964-9B8C2D0E-4CD9-450A-8E95-C0971F64308AQ40282527-7801082E-ED7D-4D5C-9FBA-7B4848916E00Q40282852-BD4C9E63-827F-45B7-BD3E-9CEB1E9E0138Q40283012-F507474A-24DF-4A98-A5F0-71002E59157CQ40283084-66A6C9B8-E7E4-491B-B6D9-5021FC77B872Q40584325-C006C04D-5DE3-484E-8E09-1730E4A0EF84Q40621581-4610A0FD-D5BA-4D2E-B985-29D2D7A5C015Q41876837-1206A3B0-CB45-479E-ADE8-6BF7AB24C995Q42015700-FEA2657B-CE1A-4310-93C0-36EF242AA3EEQ42032332-B0CD8802-FE86-4AD0-BC59-6EA0716C359BQ42115657-6C05AC21-8B1E-44E0-9183-BB49209A0CA9Q42181330-878940AB-48DA-4A58-8B9C-AACE2E82CCD2Q42929835-3CCBE6FE-35B5-4DF2-A611-541A64AD6DEDQ44013965-E0494073-9C70-47A2-A041-B8898021A54FQ44882404-C63817D6-4617-4895-A648-6CCA66AADEFDQ48135597-34A4BAA6-C899-4259-B7BF-2E0FF711FEE9Q54353071-75E2A1C1-3679-4EBE-8B16-6A7ED4143D72
P2860
In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
In vitro antibacterial activit ...... w semisynthetic cephalosporin.
@en
type
label
In vitro antibacterial activit ...... w semisynthetic cephalosporin.
@en
prefLabel
In vitro antibacterial activit ...... w semisynthetic cephalosporin.
@en
P2093
P2860
P356
P1476
In vitro antibacterial activit ...... w semisynthetic cephalosporin.
@en
P2093
Matsubara N
Mitsuhashi S
P2860
P304
P356
10.1128/AAC.16.6.731
P407
P577
1979-12-01T00:00:00Z